MONTOLIFE-DXR Tablets

Maintains Freedom in Life

COMPOSITION –

Doxofylline 10 mg (Sustained Release) + Montelukast Sodium 400 mg 

COMPOSITION:

Montelukast (Leukotriene Receptor Antagonists (LTRAs))

  • Montelukast is an antagonist to the leukotriene receptor; is non-sedating, dosed once daily, and has a safety profile similar in adults and children.
  • First-line treatment in chronic asthma, particularly effective in asthmatic patients with allergic rhinitis.

Doxofylline (Bronchodilator)

  • Doxofylline (also called as novofylline) is a newer generation xanthine with both bronchodilating and anti-inflammatory activities, with a better safety profile than that of theophylline.
  • Effectively treats patients who suffer lag from moderate to severe chronic obstructive pulmonary disease better than salbutamol.

COMBINATION:

  • Doxofylline is an effective anti-inflammatory drug, a property not shared by montelukast. 
  • Therefore, combination treatment of doxofylline + montelukast gives additional benefits compared to montelukast as monotherapy in treating lung inflammation and lung diseases.